HK Stock MarketDetailed Quotes

02315 BIOCYTOGEN-B

Watchlist
  • 8.450
  • -0.110-1.29%
Market Closed Dec 27 16:08 CST
3.37BMarket Cap-12.63P/E (TTM)

BIOCYTOGEN-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BIOCYTOGEN-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 536.589M--
Aug 28, 20242024/H1410.499M / 410.208M--
Mar 27, 20242023/H2390.076M / 367.732M--
Aug 28, 20232023/H1326.836M / 313.852M--
Mar 27, 20232022/H2304.750M / 347.693M--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 536.589M--
Aug 28, 20242024/H1410.499M / 410.208M--
Mar 27, 20242023/H2390.076M / 367.732M--
Aug 28, 20232023/H1326.836M / 313.852M--
Mar 27, 20232022/H2304.750M / 347.693M--

Unlock Free Earnings Estimates

BIOCYTOGEN-B Earnings Reports

  • BIOCYTOGEN-B: 2024 Interim Report

    Sep 25 04:45 ET

  • BIOCYTOGEN-B: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024

    Aug 28 07:46 ET

  • BIOCYTOGEN-B: DATE OF BOARD MEETING

    Aug 16 04:33 ET

  • BIOCYTOGEN-B: 2023 Annual Report

    Apr 25 05:38 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 27, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Pharmaceutical Companies
    Pharmaceutical Companies
    Intraday-0.61%